Below normal pre-procedural cardiac troponin i levels are associated with an adverse prognosis after percutaneous coronary interventions

EuroIntervention

Volumn 11, Issue 12, 2016, Pages 1380-1388

  Lupi, Alessandro ^a   Rognoni, Andrea ^a   Lazzero, Maurizio ^a   Rolla, Roberta ^a   Pergolini, Patrizia ^a   Bellomo, Giorgio ^a   Rossi, Lidia ^a   Bongo, Angelo Sante ^a   Jaffe, Allan S ^b  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; TROPONIN I; BIOLOGICAL MARKER;

AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; TARGET VESSEL FAILURE; ADVERSE EFFECTS; BLOOD; CORONARY ANGIOGRAPHY; DEVICES; DIAGNOSTIC IMAGING; DOWN REGULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STENT; TIME FACTOR; TREATMENT OUTCOME;

AGED; BIOMARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DOWN-REGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I;

EID: 84962200826     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY14M11_04     Document Type: Article

References (24)

1. Prasad A, Rihal CS, Lennon RJ, Singh M, Jaffe AS, Holmes DR Jr. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: An analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv. 2008;1:10-9.
2. Bohula May EA, Bonaca MP, Jarolim P, Antman EM, Braunwald E, Giugliano RP, Newby LK, Sabatine MS, Morrow DA. Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndromes. Clin Chem. 2014;60:158-64.
3. Okamatsu K, Takano M, Sakai S, Ishibashi F, Uemura R, Takano T, Mizuno K. Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes. Circulation. 2004;109:465-70.
4. Korosoglou G, Lehrke S, Mueller D, Hosch W, Kauczor HU, Humpert PM, Giannitsis E, Katus HA. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart. 2011;97:823-31.
5. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361:858-67.
6. Kavsak PA, Worster A, You JJ, Oremus M, Shortt C, Phan K, Sohn KY, Veljkovic K, Devereaux PJ, Hill S, Bhanich-Supapol W, Jaffe AS. Ninety-minute vs 3-h performance of high-sensitivity cardiac troponin assays for predicting hospitalization for acute coronary syndrome. Clin Chem. 2013;59:1407-10.
7. Korley FK, Jaffe AS. Preparing the United States for high-sensitivity cardiac troponin assays. J Am Coll Cardiol. 2013;61:1753-8.
8. Omland T, Pfeffer MA, Solomon SD, de Lemos JA, Ru¸sju¸ H, Benth J, Maggioni A, Domanski MJ, Rouleau JL, Sabatine MS, Braunwald E; PEACE Investigators. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013;61:1240-9.
9. Beatty AL, Ku IA, Christenson RH, DeFilippi CR, Schiller NB, Whooley MA. High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul study. JAMA Intern Med. 2013;173:763-9.
10. McKie PM, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ, Redfield MM, Burnett JC Jr, Jaffe AS. Defining high-sensitivity cardiac troponin concentrations in the community. Clin Chem. 2013;59:1099-107.
11. Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R, Apple FS. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012;58:219-25.
12. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. Third universal definition of myocardial infarction. Circulation. 2012;126:2020-35.
13. Rits IA. Declaration of Helsinki. Recommendations Guidings Doctors in Clinical Research. World Med J. 1964;11:281.
14. Koenig W, Breitling LP, Hahmann H, Wösten B, Brenner H, Rothenbacher D. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin Chem. 2012;58:1215-24.
15. Kavsak PA, Xu L, Yusuf S, McQueen MJ. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin Chem. 2011;57:1146-53.
16. Jaffe AS, Apple FS, Lindahl B, Mueller C, Katus HA. Why all the struggle about CK-MB and PCI? Eur Heart J. 2012;33:1046-8.
17. Chatterjee S, Kim J, Dahhan A, Choudhary G, Sharma S, Wu WC. Use of high-sensitivity troponin assays predicts mortality in patients with normal conventional troponin assays on admission-insights from a meta-Analysis. Clin Cardiol. 2013;36:649-53.
18. Pervanidou P, Akalestos A, Bastaki D, Apostolakou F, Papassotiriou I, Chrousos G. Increased circulating high-sensitivity troponin T concentrations in children and adolescents with obesity and the metabolic syndrome: A marker for early cardiac damage? Metabolism. 2013;62:527-31.
19. Ndrepepa G, Braun S, Mehilli J, Birkmeier KA, Byrne RA, Ott I, Hösl K, Schulz S, Fusaro M, Pache J, Hausleiter J, Laugwitz KL, Massberg S, Seyfarth M, Schömig A, Kastrati A. Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am Heart J. 2011;161:68-75.
20. Tang WH, Wu Y, Nicholls SJ, Brennan DM, Pepoy M, Mann S, Pratt A, Van Lente F, Hazen SL. Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation. Arterioscler Thromb Vasc Biol. 2010;30:634-40.
21. Testa L, Latini RA, Agostoni P, Banning AP, Bedogni F. Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery. Am J Cardiol. 2009;103:1622-3.
22. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, Hoogeveen RC, Liu X, Astor BC, Mosley TH, Folsom AR, Heiss G, Coresh J, Ballantyne CM. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation. 2011;123:1367-76.
23. Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med. 2011;364:453-64.
24. Koh JS, Park JH, Shin DH, Youn TJ, Oh IY, Yoon CH, Suh JW, Cho YS, Cho GY, Chae IH, Choi DJ. Risk factors and effects on long-Term outcomes of cardiac troponin I elevation after drug-eluting stent implantation in patients with stable coronary artery disease. Am J Cardiol. 2012;109:461-5.